Pharma Journalist - Page 62 of 956 -

Sanofi, Regeneron Expand Antibody Collaboration With $8B Deal

Abogen, Novartis Sign $7.2B RNA Therapeutics Deal

CAS, Novartis Partner on AI-Ready Reaction Data for Drug Discovery

Novo Nordisk Alzheimer’s Trials Show No Benefit for Semaglutide

FDA Approves First Gene Therapy for Broad SMA Patient Population

Vaximm Enters Talks for Global License of Oral Cancer Therapy

AstraZeneca to Invest $2 Billion in Major Maryland Expansion

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to $2.37 Billion

EU Grants Conditional Approval for Roche’s One-Minute Subcutaneous Lunsumio in Follicular Lymphoma

Novartis to Build Major U.S. Manufacturing Hub in North Carolina

FDA Approves Expanded Dosing Options for Regeneron’s EYLEA HD in Retinal Diseases

Moderna Expands U.S. Manufacturing with New Onshore Drug Product Facility

Merck’s Two-Drug HIV Regimen Meets Phase 3 Trial Goals